首页 | 本学科首页   官方微博 | 高级检索  
     

肾病综合征合并肺栓塞的临床研究进展
引用本文:贾安佩 单剑萍 蒋更如. 肾病综合征合并肺栓塞的临床研究进展[J]. 现代生物医学进展, 2015, 15(28): 5576-5578
作者姓名:贾安佩 单剑萍 蒋更如
作者单位:上海交通大学医学院附属新华医院肾内科
摘    要:肾病综合征是一种临床常见疾病,其患者体内常呈高凝状态,极易发生血栓栓塞事件,而其中以肾静脉血栓、肺动脉栓塞和下肢深静脉血栓最为常见。由于肺动脉栓塞早期缺乏特征性的临床表现,病情隐匿,所以极易误诊或漏诊,发现时患者病情往往已十分严重,致死率极高。目前,对于肾病综合征合并肺栓塞的发生率国内外报道不一,尚无准确的流行病学资料,而对于其发病原因、危险因素、早期诊断及是否需要预防性抗凝治疗等均存在争议,本文主要结合文献对肾病综合征合并肺栓塞的流行病学、病因及发病机制、诊断、高危因素和治疗进行了综述,尤其是对目前争议较大的肾病综合征合并肺栓塞患者是否需要早期抗凝治疗。

关 键 词:肾病综合征;肺栓塞;发病机制;诊断;治疗;预防性抗凝

Clinical Research Progress of Pulmonary Embolismin Nephrotic Syndrome
Abstract:Nephrotic syndrome is a common clinical disease. Patients with nephritic syndrome are often in the hpercoagulablestate. Renal vein thrombosis, pulmonary embolism and deep vein thrombosis are the most common thromboembolism diseases. Amongthem, pulmonary embolism is the most dangerous because of its high mortality. Due to the lack of obvious and characteristic clinicalmanifestation in the early stage, pulmonary embolismis prone to be misdiagnosed or never diagnosed. However, the epidemiological datareported of nephrotic syndrome with pulmonary embolism shows no consistency at home and abroad, there is still debate about the causeof disease, risk factors, early diagnosis and the need for anticoagulation therapy. The purpose of this essay is to describe theepidemiology, pathophysiological mechanisms, diagnosis and treatment of pulmonary embolism in patients with nephrotic syndrome,especially for the present controversial about the necessity of early anticoagulation therapy of patients with nephrotic syndromecomplicated with pulmonary embolism.
Keywords:Nephrotic Syndrome   Pulmonary Embolism   Pathophysiology   Diagnosis   Treatment   Prophylactic anticoagulation
本文献已被 万方数据 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号